NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells
<p>Abstract</p> <p>Background</p> <p>NF-κB is a transcription factor that promotes inhibition of apoptosis and resistance to chemotherapy. It is commonly believed that inhibition of NF-κB activity can increase sensitivity of cancer cells to chemotherapy. However, there...
Main Authors: | Parrondo Ricardo, Pozas Alicia, Reiner Teresita, Rai Priyamvada, Perez-Stable Carlos |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/182 |
Similar Items
-
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
by: Ricardo Parrondo, et al.
Published: (2013-09-01) -
Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
by: Teresita Reiner, et al.
Published: (2013-01-01) -
Modeling Cancer Cell Growth Dynamics In vitro in Response to Antimitotic Drug Treatment
by: Alexander Lorz, et al.
Published: (2017-08-01) -
HSP90 inhibition enhances antimitotic drug-induced mitotic arrest and cell death in preclinical models of non-small cell lung cancer.
by: Brenda C O'Connell, et al.
Published: (2014-01-01) -
Photopharmacology of Antimitotic Agents
by: Susanne Kirchner, et al.
Published: (2022-05-01)